Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Maintains Buy on Toast, Lowers Price Target to $30

Needham Maintains Buy on Toast, Lowers Price Target to $30

Needham analyst Mayank Tandon maintains Toast (NYSE:TOST) with a Buy and lowers the price target from $32 to $30.

byBenzinga Newsdesk

February 17, 2023

1 minute read

Needham analyst Mayank Tandon maintains Toast (NYSE:TOST) with a Buy and lowers the price target from $32 to $30.

Raymond James Downgrades UserTesting to Market Perform

By Benzinga Newsdesk

December 13, 8:21 AM

Raymond James analyst Brian Peterson downgrades UserTesting (NYSE:USER) from Strong Buy to Market Perform.

USER

Why Are Inpixon Shares Trading Higher Premarket Today

By Anusuya Lahiri

March 31, 6:39 AM

Inpixon (NASDAQ: INPX) shares gained premarket Friday after reporting FY22 results on Thursday.

INPX

News

EpicQuest Education Announces New Milestone In Davis University Designation

By Benzinga Newsdesk

November 28, 9:35 AM

The Davis University Designation Broadens Students' Academic Journeys which is Expected to Increase Enrollment and RevenueMIDDLETOWN, Ohio, Nov. 28, 2023 /PRNewswire/ -- EpicQuest Education Group International

EEIQ

GSK’s Rare Blood Cancer Candidate Goes Under FDA Review

By Vandana Singh

August 17, 8:44 AM

The FDA has accepted GSK plc’s (NYSE:GSK) marketing application for momelotinib, a potential new medicine with a proposed differentiated mechanism of…

GSK

Needham Maintains Buy on Toast, Lowers Price Target to $30

Related Posts

Raymond James Downgrades UserTesting to Market Perform

Why Are Inpixon Shares Trading Higher Premarket Today

EpicQuest Education Announces New Milestone In Davis University Designation

GSK’s Rare Blood Cancer Candidate Goes Under FDA Review